THE PRECISION BIO-INTELLIGENCE FRAMEWORK FOR COMBATING MRSA AND PERSONALIZED MEDICINE FROM MOLECULAR DIAGNOSTICS TO GENE-EDITING THERAPIES A Unified Theory of Antimicrobial Resistance, Ultra-Early Detection, AI-Driven Drug Discovery, Personalized Genetic and Cellular Therapy, and Health Law
Abstract
The Precision Bio-Intelligence Framework for Combating MRSA and Personalized Medicine by Dr. M.K.A. El-Rakhawi (DOI: 10.5281/zenodo.23462676) establishes Precision Bio-Intelligence as a groundbreaking field integrating antimicrobial resistance, ultra-early detection, AI-driven drug discovery, genetic/cellular therapy, and health law through four pillars: (1) Biological Foundations exploring MRSA mecA/PBP2a resistance, Monod growth kinetics mu=mu_max*S/(K_s+S), and Cheng-Prusoff MIC_apparent=MIC_intrinsic*(1+[I]/K_i) for competitive resistance; (2) AI and Drug Discovery featuring cross-entropy loss L=-1/N*sum(y_i*log(p_i)+(1-y_i)*log(1-p_i)), Graph Neural Networks h_i^(l+1)=sigma(sum(W^(l)*h_j^(l))), and FICI synergy indices; (3) Genetic/Cellular Therapy covering high-fidelity CRISPR variants (SpCas9-HF1, eSpCas9, HiFi Cas9), Campbell Model phage-bacteria dynamics dB/dt=r*B*(1-B/K)-phi*B*P, dP/dt=beta*phi*B*P-d*P-phi*B*P, and Hill dose-response E=E_max*[D]^n/(EC_50^n+[D]^n); (4) Legal Frameworks addressing Myriad v. AMP (2013), EPC Rule 29(1) excluding natural gene patenting, GDPR genetic data protections, and WHO Global AMR Governance. Novel concepts include CRISPR-phages, AI-accelerated antibiotic discovery, and personalized pharmacogenomics. Applications span MRSA treatment, phage therapy, CAR-T immunotherapy, and global AMR stewardship. Protected under international copyright with multiple citation formats (APA, Chicago, MLA, Harvard, IEEE, Vancouver).
